News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Resverlogix Corporation (RVX.TO) Conference Call & Webcast Announcement



2/7/2014 6:22:43 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

TSX Exchange Symbol: RVX

CALGARY, Feb. 6, 2014 /PRNewswire/ - Resverlogix Corp. (TSX:RVX) will be hosting a conference call and webcast on Thursday, February 13, 2014 at 11 am MDT / 1 pm ET. The call will update the market on current clinical and business structure options.

Details for the conference call and webcast are as follows:

Link to webcast: http://services.choruscall.ca/links/resverlogix140213.html

Dial in numbers:
Canada & USA Toll Free Dial In: 1-800-319-4610
Outside of Canada & USA call: +1-604-638-5340

About Resverlogix

Resverlogix Corp. (TSX:RVX) is a clinical stage biotechnology company developing compounds involving ApoA-I production. RVX-208 is a first-in-class small molecule in development for the treatment of diseases such as atherosclerosis, Diabetes Mellitus and Alzheimer's disease. RVX-208 is the first BET bromodomain inhibitor in clinical trials. Resverlogix's common shares trade on the Toronto Stock Exchange (TSX: RVX). For further information please visit www.resverlogix.com. We can be followed on our blog at http://www.resverlogix.com/blog and our IR App found on Apple products iTunes and Android users (Google Play).

Company Contacts:
Donald J. McCaffrey
President and CEO
Resverlogix Corp.
Phone: 403-254-9252
Email: don@resverlogix.com
Kenneth Lebioda
SVP Business & Corporate Development
Resverlogix Corp.
Phone: 403-254-9252
Email: ken@resverlogix.com

SOURCE Resverlogix Corp.



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES